Relucent Exploration Tech

Description

Our regulatory and quality personnel have a broad background of diverse expertise in submissions and quality assurance development, from product concept through product launch in both domestic and international markets. We have extensive experience in the areas of minimally invasive cardiovascular products and permanent implants, as well as topical pharmaceuticals, orthopedics, surgical and endoscopic instrumentation, glucose monitoring devices, and MRI equipment. Our team has worked with companies of all sizes from start-ups to established multinational corporations.

For particularly demanding applications, optimization of your product design can best be accomplished with the aid of finite element analysis. Our years of experience modeling medical devices will speed the development of your new medical device. Not only will the implementation of FEA bolster your product submission to the FDA, it will also reduce the number of development cycles needed–saving your company valuable time and money.

Optimizing your process to best meet your product specifications is one of the core competencies of Relucent Solutions. With our vast experience in a wide range of alloys, designs, and processes we can help determine the best solutions for your product and design specifications.

Steve Parmelee has worked in high-tech manufacturing companies for over 10 years, and has held central engineering positions in large companies such as Komag Material Technologies (Santa Rosa, CA), TriVascular (Santa Rosa, CA) which was acquired by Boston Scientific, and Memry Corporation (Menlo Park, CA). Parmelee has focused his career on taking prototype concepts to successful high-volume manufacturing (Komag Material Technologies produced 120,000 hard disk drive substrates a day), while developing business expertise in departments such as R&D, process development, manufacturing, metrology and quality. Parmelee holds a degree in mechanical engineering from the University of California at Santa Barbara.

Maurice De La Rosa has worked in the medical device field for over 14 years, at companies such as St. Jude Medical, Perclose (acquired by Abbott), and TriVascular (acquired by Boston Scientific). He has spent the majority of that time in R&D and product development, working on teams tasked with rapid development cycles. Most recently he spent 6 years at TriVascular closely involved in the design and development of the stents for TriVascular’s innovative AAA stent-graft, before moving on to help found Relucent Solutions. He received a B.S. in mechanical engineering from California Polytechnic San Luis Obispo, and is the holder of 19 issued and pending patents related to designs and innovations in the medical device field.

Products & services